Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-x5gtn Total loading time: 0 Render date: 2024-05-14T16:10:56.571Z Has data issue: false hasContentIssue false

Chapter 24 - Human immunodeficiency virus in the elderly

from Section III - Care of the elderly by organ system

Published online by Cambridge University Press:  05 June 2016

Jan Busby-Whitehead
Affiliation:
University of North Carolina
Christine Arenson
Affiliation:
Thomas Jefferson University, Philadelphia
Samuel C. Durso
Affiliation:
The Johns Hopkins University School of Medicine
Daniel Swagerty
Affiliation:
University of Kansas
Laura Mosqueda
Affiliation:
University of Southern California
Maria Fiatarone Singh
Affiliation:
University of Sydney
William Reichel
Affiliation:
Georgetown University, Washington DC
Get access

Summary

It is estimated that more than half of those living with human immunodeficiency virus (HIV) infection in the United States are now at least 50 years of age. Infection with HIV may be under-diagnosed in older persons, both because they may be perceived as being at lower risk for infection and because manifestations of HIV-related complications are mistaken for conditions associated with aging. The management of the HIV-infected older patient can be challenging due to comorbid diseases and polypharmacy. As HIV-infected persons are at increased risk for cardiovascular disease, certain malignancies, low bone density, as well as mental health disorders and substance abuse, successful medical care of these individuals requires careful attention to screening guidelines and a coordinated multidisciplinary approach.
Type
Chapter
Information
Reichel's Care of the Elderly
Clinical Aspects of Aging
, pp. 344 - 356
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Centers for Disease Control. HIV among older Americans, 2013. Available at: www.cdc.gov/hiv/risk/age/olderamericans/index.html (accessed December 4, 2014).Google Scholar
O’Keefe, KJ, Scheer, S, Chen, MJ, et al. People fifty years or older now account for the majority of AIDS cases in San Francisco, California, 2010. AIDS Care. 2013;25(9):1145–8.Google Scholar
CDC. HIV Surveillance Report, 2011. Available at: www.cdc.gov/hiv/library/reports/surveillance/2011/surveillance_Report_vol_23.html (accessed December 4, 2014).Google Scholar
Samji, H, Cescon, A, Hogg, RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013 Dec 18;8(12):e81355.CrossRefGoogle ScholarPubMed
Luther, VP, Wilkin, AM. HIV infection in older adults. Clin Geriatr Med. 2007 Aug;23(3):567–83, vii.CrossRefGoogle ScholarPubMed
Illa, L, Brickman, A, Saint-Jean, G, et al. Sexual risk behaviors in late middle age and older HIV seropositive adults. AIDS Behav. 2008 Nov;12(6):935–42.CrossRefGoogle ScholarPubMed
Lekas, HM, Schrimshaw, EW, Siegel, K. Pathways to HIV testing among adults aged fifty and older with HIV/AIDS. AIDS Care. 2005 Aug;17(6):674–87.Google Scholar
Branson, BM, Handsfield, HH, Lampe, MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006 Sep 22;55(RR-14):117.Google Scholar
US Preventive Services Task Force. AHRQ publication number 12–05173-EF-3. April 2013. Available at: www.cdc.gov/nchhstp/preventionthroughhealthcare/preventiveservices/hivaids.htm (accessed February 4, 2016).Google Scholar
Lindau, ST, Schumm, LP, Laumann, EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007 Aug 23;357(8):762–74.CrossRefGoogle ScholarPubMed
CDC and APHL. Laboratory testing for the diagnosis of HIV infection: updated recommendations. Version June 27, 2014. Available at: http://stacks.cdc.gov/view/cdc/23447 (accessed February 4, 2016).Google Scholar
Stoff, DM, Khalsa, JH, Monjan, A, Portegies, P. Introduction: HIV/AIDS and Aging. AIDS. 2004 Jan 1;18(Suppl 1):S12.Google Scholar
Observational HIV Epidemiological Research Europe (COHERE) Study Group, Sabin, CA, Smith, CJ, et al. Response to combination antiretroviral therapy: variation by age. AIDS. 2008 Jul 31;22(12):1463–73.Google Scholar
Heaton, RK, Franklin, DR, Ellis, RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011 Feb;17(1):316.CrossRefGoogle ScholarPubMed
Ances, BM, Ellis, RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol. 2007 Feb;27(1):8692.Google Scholar
McArthur, JC, Haughey, N, Gartner, S, et al. Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol. 2003 Apr;9(2):205–21.Google Scholar
Engels, EA, Biggar, RJ, Hall, HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008;123:187–94.Google Scholar
Szerlip, MA, DeSalvo, KB, Szerlip, HM. Predictors of HIV-infection in older adults. J Aging Health. 2005 Jun;17(3):293304.Google Scholar
Guaraldi, G, Orlando, G, Zona, S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011 Dec;53(11):1120–6.Google Scholar
Goulet, JL, Fultz, SL, Rimland, D, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007;45:15931601.Google Scholar
Losina, E, Linas, B, Hyle, E, et al. Projecting 10-year, 20-year, and lifetime risks of cardiovascular disease in HIV+ individuals in the US: competing risks and premature aging. Program and abstracts of the 20th Conference on Retroviruses and Opportunistic Infections; March 3–6, 2013; Atlanta, GA. Abstract 747.Google Scholar
Bhavan, KP, Kampalath, VN, Overton, ET. The aging of the HIV epidemic. Curr HIV/AIDS Rep. 2008;5:150–8.Google Scholar
Triant, VA, Lee, H, Hadigan, C, Grinspoon, SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007 Jul;92(7):2506–12.Google Scholar
Johnsen, S, Dolan, SE, Fitch, KV, et al. Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome. J Clin Endocrinol Metab. 2006 Dec;91(12):4916–24.CrossRefGoogle ScholarPubMed
Post, WS, Budoff, M, Kingsley, L, et al. Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med 2014 Apr 1;160(7):458–67.CrossRefGoogle ScholarPubMed
Bedimo, R, Zhang, S, Drechsler, H, et al. Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. Program and abstracts of the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention; July 17–20, 2011; Rome, Italy. Abstract MoAB0101.Google Scholar
Gebo, KA, Justice, A. HIV infection in the elderly. Curr Infect Dis Rep. 2009 May;11(3):246–54.Google Scholar
Margolick, J, Detels, R, Phair, J, et al. Earlier occurrence of the frailty phenotype in HIV+ men than HIV- men: the MACS. Program and abstracts of the 18th Conference on Retroviruses and Opportunistic Infections; February 27–March 2, 2011; Boston, MA. Abstract 794.Google Scholar
Deeks, SG, Lewin, SR, Havlir, DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013 Nov 2;382(9903):1525–33.CrossRefGoogle ScholarPubMed
Hunt, PW, Martin, JN, Sinclair, E, et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis. 2003 May 15;187(10):1534–43.Google Scholar
Sandler, NG, Wand, H, Roque, A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011 Mar 15;203(6):780–90.Google Scholar
Brenchley, JM, Prince, DA, Schacker, TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006 Dec;12(12):1365–71.Google Scholar
Hunt, PW, Martin, JN, Sinclair, E, et al. Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis. 2011 May 15;203(10):1474–83.Google Scholar
Fitch, KV, Looby, SE, Rope, A, et al. Effects of aging and smoking on carotid intima-media thickness in HIV-infection. AIDS. 2013 Jan 2;27(1):4957.Google Scholar
Sabin, C, Reiss, P, Ryom, L, et al. Is there continued evidence for an association between abacavir and myocardial infarction risk? Program and abstracts of the 21st Conference on Retroviruses and Opportunistic Infections; March 3–6, 2013; Boston, MA. Abstract 747LB.Google Scholar
Lichtenstein, KA, Armon, C, Buchacz, K, et al; HIV Outpatient Study (HOPS) Investigators. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis. 2010;51:435–47.Google Scholar
Lichtenstein, KA, Armon, C, Buchacz, K, et al. Initiation of antiretroviral therapy at CD4 cell counts ≥350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency. J Acquir Immune DeficSyndr. 2008;47(1):2735.Google Scholar
Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006 Nov 30;355(22):2283–96.Google Scholar
Klein, DB, Leyden, WA, Chao, CR, et al. No difference in incidence of myocardial infarction for HIV+ and HIV- individuals in recent years. Program and abstracts of the 21st Conference on Retroviruses and Opportunistic Infections; March 3–6, 2013; Boston, MA. Abstract 737.Google Scholar
Llibre, JM, Falco, V, Tural, C, et al. The changing face of HIV/AIDS in treated patients. Curr HIV Res. 2009 Jul;7(4):365–77.Google Scholar
Justice, AC, McGinnis, KA, Skanderson, M, et al.; VACS Project Team. Towards a combined prognostic index for survival in HIV infection: the role of “non-HIV” biomarkers. HIV Med. 2010 Feb;11(2):143–51.Google Scholar
White, JR, Chang, CH, Butt, AA, et al. Depression and HIV are risk factors for incident heart failure among veterans [CROI abstract 726]. In Special Issue: Abstracts from the 2014 Conference on Retroviruses and Opportunistic Infections. Top Antivir Med. 2014;22(e-1):369–70.Google Scholar
Atkinson, JH, Heaton, RK, Patterson, TL, et al. Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord. 2008 Jun;108(3):225–34.Google Scholar
Khambaty, T, Stewart, JC, Gupta, SK, et al. Depression predicts incident myocardial infarction in HIV+ veterans: Veterans Aging Cohort Study [CROI abstract 735]. In Special Issue: Abstracts from the 2014 Conference on Retroviruses and Opportunistic Infections. Top Antivir Med. 2014;22(3-1):375.Google Scholar
Batten, SV, Aslan, M, Maciejewski, PK, Mazure, CM. Childhood maltreatment as a risk factor for adult cardiovascular disease and depression. J Clin Psychiatry. 2004 Feb;65(2):249–54.CrossRefGoogle ScholarPubMed
Dale, S, Franklin, G, Kelso, R, et al. Childhood sexual abuse, traditional gender roles, and coronary heart disease risk among women with HIV. Second International Workshop on HIV & Women; 2012. Abstract P_14.Google Scholar
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at: http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (accessed December 4, 2014).Google Scholar
Garg, S, Furlow-Parmley, C, Frazier, E, et al. Prevalence of chronic kidney disease among HIV+ adults in care in the US: medical monitoring Project 2009. [CROI abstract 809]. Program and abstracts of the 20th Conference on Retroviruses and Opportunistic Infections. March 3–6, 2013; Atlanta, GA.Google Scholar
Wyatt, CM. Antiretroviral therapy and the kidney. Top Antivir Med. 2014 Jun–Jul;22(3):655–8.Google Scholar
Rockwood, N, Mandalia, S, Bower, M, et al. Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir. AIDS. 2011 Aug 24;25(13):1671–3.Google Scholar
Gebo, KA, Diener-West, M, Moore, RD. Hospitalization rates differ by hepatitis C satus in an urban HIV cohort. J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):165–73.Google Scholar
McCommey, GA, Tebas, P, Shane, E, et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis. 2010 Oct 15;51(8):937–46.Google Scholar
Tebas, P, Powderly, WG, Claxton, S, et al. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS. 2000 Mar 10;14(4):F63–7.Google Scholar
Overton, ET, Chan, ES, Brown, TT, et al. High-dose vitamin D and calcium attenuates bone loss with ART initiation: results from ACTG A5280 [CROI abstract 133]. In Special Issue: Abstracts from the 2014 Conference on Retroviruses and Opportunistic Infections. Top Antivir Med. 2014;22(e-1):66–7.Google Scholar
National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010.Google Scholar
University of Sheffield U. FRAX WHO Fracture Risk Assessment Tool. Available at: www.shef.ac.uk/FRAX/tool.aspx (accessed December 4, 2014).Google Scholar
Skapik, JL, Treisman, GJ. HIV, psychiatric comorbidity, and aging. Clinical Geriatrics. 2007(15):2636.Google Scholar
Gonzalez, JS, Batchelder, AW, Psaros, C, Safren, SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):181–7.Google Scholar
Goodkin, K. Psychiatric aspects of HIV spectrum disease. Focus Psychiatry Review. 2007;7(3):303–10.Google Scholar
Zanjani, F, Saboe, K, Oslin, D. Age difference in rates of mental health/substance abuse and behavioral care in HIV-positive adults. AIDS Patient Care Stds. 2007 May;21(5):347–55.Google Scholar
Work Group for HIV and Aging Consensus Project. Summary report from the Human Immunodeficiency Virus and Aging Consensus Project: treatment strategies for clinicians managing older individuals with the human immunodeficiency virus. J Am Geriatr Soc. 2012 May;60(5):974–9.Google Scholar
Power, C, Selnes, OA, Grim, JA, McArthur, JC. HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 1;8(3):273–8.Google Scholar
Valcour, V, Paul, R, Chiao, S, et al. Screening for cognitive impairment in human immunodeficiency virus. Clin Infect Dis. 2011 Oct;53(8):836–42.Google Scholar
Oursler, KK, Sorkin, JD, Smith, BA, Katzel, LI. Reduced aerobic capacity and physical functioning in older HIV-infected men. AIDS Res Hum Retroviruses. 2006 Nov;22(11):1113–21.Google Scholar
Shippy, RA, Karpiak, SE. The aging HIV/AIDS population: fragile social networks. Aging Ment Health. 2005 May;9(3):246–54.Google Scholar
Brennan, DJ, Emlet, CA, Eady, A. HIV, sexual health, and psychosocial issues among older adults living with HIV in North America. Ageing International. 2011;36(3):313–33.CrossRefGoogle Scholar
Silverberg, MJ, Leyden, W, Horberg, MA, et al. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007 Apr 9;167(7):684–91.Google Scholar
Vance, DE, Burrage, JW. Promoting successful cognitive aging in adults with HIV: strategies for intervention. J Gerontol Nurs. 2006 Nov;32(11):3441Google Scholar
Centers for Disease Control. HIV surveillance report: diagnoses of HIV infection and AIDS in the United States and dependent areas, 2011. Available at: www.cdc.gov/hiv/statistics/basics (accessed December 4, 2014).Google Scholar
Goodroad, BK. HIV and AIDS in people older than 50: a continuing concern. J Gerontol Nurs. 2003 Apr;29(4):1824.Google Scholar
Linsk, NL. HIV among older adults: age-specific issues in prevention and treatment. AIDS Read. 2000 Jul;10(7):430–40.Google Scholar
Skiest, DJ, Keiser, P. Human immunodeficiency virus infection in patients older than 50 years: a survey of primary care physicians’ beliefs, practices, and knowledge. Arch Fam Med. 1997 May–Jun;6(3):289–94.Google Scholar
Orel, NA, Wright, JM, Wagner, J. Scarcity of HIV/AIDS risk-reduction materials targeting the needs of older adults among state departments of public health. Gerontologist. 2004 Oct;44(5):693–6.Google Scholar
Centers for Disease Control and Prevention. HIV-related knowledge and stigma: United States, 2000. MMWR. 2000;49(RR47):1062–4.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×